Latest Morning Briefing Stories
A Progress Check on Hospital Price Transparency
Hospitals are facing mixed reviews regarding their efforts to comply with a federal requirement that they post information about prices related to nearly every health care service they provide.
ER’s Error Lands a 4-Year-Old in Collections (For Care He Didn’t Receive)
A Florida woman tried to dispute an emergency room bill, but the hospital and collection agency refused to talk to her — because it was her child’s name on the bill, not hers.
Truly Random Drug Testing: ADHD Patients Face Uneven Urine Screens and, Sometimes, Stigma
Doctors have no national standards on when to order urine tests to check whether adult ADHD patients are properly taking their prescription stimulants. Some patients are subjected to much more frequent testing than others.
Journalists Delve Into Insulin Costs and Prior Authorization Policy
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Health Providers Scramble to Keep Remaining Staff Amid Medicaid Rate Debate
The ranks of community-based behavioral health providers in Montana have diminished amid rising costs, greater need, and stagnant Medicaid reimbursement rates. Now, as state lawmakers debate solutions, providers are hoping just to cover their costs.
Sen. Sanders Shows Fire, but Seeks Modest Goals, in His Debut Drug Hearing as Health Chair
The Vermont independent and former presidential candidate was all fire and brimstone at his first hearing on drug prices as head of the Senate HELP Committee. He also pursued a more modest goal of covid vaccine price reductions. It isn’t clear whether Sanders will succeed in even that, but he has put affordability front and center.
Legal Questions, Inquiries Intensify Around Noble Health’s Rural Missouri Hospital Closures
A year after private equity-backed Noble Health shuttered two rural Missouri hospitals, a slew of lawsuits and state and federal investigations grind forward. Missouri Attorney General Andrew Bailey recently confirmed an “ongoing” investigation as former employees continue to go unpaid and cope with unpaid medical claims.
California Picks Generic Drug Company Civica to Produce Low-Cost Insulin
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He’s also eyeing other generic drugs.
California eligió a la compañía de genéricos Civica para producir insulina de bajo costo
Civica está desarrollando tres tipos de insulina genérica, conocida como biosimilar, que estarán disponibles tanto en viales como en plumas inyectables, a un costo de entre $30 y $55.
Journalists Discuss Medicaid Unwinding and Clawbacks
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Temp Nurses Cost Hospitals Big During Pandemic. Lawmakers Are Now Mulling Limits.
Missouri is considering making it a felony to jack up temporary health care staffing prices during a statewide or national emergency. It’s one of at least 14 states looking to reel in travel nurse costs, after many hospitals struggled to pay for needed staffers earlier in the covid pandemic.
Listen to ‘Tradeoffs’: Medical Debt Delivers ‘A Shocking Amount of Misery’
Medical debt in America pushes families to the edge. Ariane Buck and his wife, Samantha, were denied care at their doctor’s office because of an unpaid bill of less than $100. A trip to the emergency room added thousands of dollars to their health care debt, which topped $50,000 by the time they filed for bankruptcy.
Two Counties Square Off With California Over Mental Health Duties
The state wants to stop paying Kaiser Permanente for treating severely mentally ill Medi-Cal patients in Sacramento and Solano counties and force the counties to take on the task. The counties’ leaders say they can’t afford it.
An Arm and a Leg: Wrestling With a Giant: How to Dispute a Hospital Bill
One listener tried to dispute a $1,300 “facility fee” with the treating hospital, his insurer, a bill-mediation service provided by his employer, and finally a debt collector. He didn’t win, but he learned valuable lessons about advocating for hospital discounts.
KFF Health News' 'What the Health?': Biden Budget Touches All the Bases
Very little in the proposed budget released by the Biden administration is likely to become law, particularly with Republicans in charge of the U.S. House. Still, the document is an important statement of the president’s policy priorities, and it’s clear health programs are among those he feels are important. Meanwhile, five women who were denied abortions when their pregnancies threatened their lives are suing Texas. Shefali Luthra of The 19th, Victoria Knight of Axios, and Margot Sanger-Katz of The New York Times join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Harris Meyer, who reported and wrote the two latest KHN-NPR “Bill of the Month” features. Both were about families facing unexpected bills following childbirth.
Planes de salud de Medicaid intentan proteger a sus miembros… y a sus ganancias
Estos planes, muchos administrados por titanes de los seguros, incluidos UnitedHealthcare, Centene y Aetna, han visto aumentar sus ingresos en miles de millones a medida que su membresía aumentaba en millones.
A los pocos meses de usar AGGA, una paciente dijo que sus dientes estaban tan flojos que podía sentir cómo se movían cuando se untaba crema hidratante en las mejillas. Besar a su novio le resultaba incómodo.
La insulina representa lo perverso del sistema sanitario estadounidense, ya que los precios de venta de este medicamento centenario, del que dependen 8,4 millones de estadounidenses para sobrevivir, se quintuplicaron en dos décadas.
Medicaid Health Plans Try to Protect Members — And Profits — During Unwinding
States are turning to the big health insurance companies to keep Medicaid enrollees insured once pandemic protections end in April. The insurers’ motive: profits.
Why Does Insulin Cost So Much? Big Pharma Isn’t the Only Player Driving Prices
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but it’s the arbitrators that jack up prices for those who can least afford them.
